白质病变与急性缺血性卒中血管内治疗结局:MR CLEAN登记结果
本研究基于荷兰MR CLEAN登记的前瞻性多中心观察队列,纳入3180例接受血管内治疗的急性缺血性卒中患者,其中3046例完成基线平扫CT白质病变分级。结果显示白质病变负荷越重,90天功能结局越差,呈剂量依赖关系,但与成功再灌注或症状性颅内出血无关。
要点
- 白质病变负荷越重,血管内治疗后90天功能结局越差,呈剂量依赖关系。
- 白质病变严重程度与无效再通相关,与早期神经功能恢复呈负相关。
- 白质病变负荷不影响成功再灌注或症状性颅内出血的概率。
核心结论
- 基线白质病变负荷增加与急性缺血性卒中血管内治疗后更差的临床结局相关,但与成功再灌注或症状性颅内出血的概率无关。
主要发现
- 白质病变分级为无1855例(61%)、轻度608例(20%)、中重度588例(19%)。
- 90天改良Rankin量表评分0–2分的良好结局:无白质病变838例(49%)、轻度192例(34%)、中重度130例(24%)。
- 白质病变分级增加与功能结局变差呈剂量依赖关系:轻度调整共同比值比1.34(95%CI 1.13–1.60),中重度1.67(95%CI 1.39–2.01),P趋势<0.001。
- 白质病变分级增加与无效再通相关(P趋势<0.001),与早期神经功能恢复呈负相关(P趋势=0.041),与成功再灌注或症状性颅内出血无显著关联。
临床怎么用
- 对接受血管内治疗的急性缺血性卒中患者,基线白质病变负荷可用于辅助预判功能结局和无效再通风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebral white matter lesions (WMLs) have been associated with a greater risk of poor functional outcome after ischemic stroke. We assessed the relations between WML burden and radiological and clinical outcomes in patients treated with endovascular treatment in routine practice. METHODS: We analyzed data from the MR CLEAN Registry (Multicenter Randomized Controlled Trial of Endovascular Treatment for Acute Ischaemic Stroke in the Netherlands)—a prospective, multicenter, observational cohort study of patients treated with endovascular treatment in the Netherlands. WMLs were graded on baseline noncontrast computed tomography using a visual grading scale. The primary outcome was the score on the modified Rankin Scale at 90 days. Secondary outcomes included early neurological recovery, successful reperfusion (extended Thrombolysis in Cerebral Infarction ≥2b), futile recanalization (modified Rankin Scale score ≥3 despite successful reperfusion), and occurrence of symptomatic intracranial hemorrhage. We used multivariable logistic regression models to assess associations between WML severity and outcomes, taking the absence of WML on noncontrast computed tomography as the reference category. RESULTS: Of 3180 patients included in the MR CLEAN Registry between March 2014 and November 2017, WMLs were graded for 3046 patients and categorized as none (n=1855; 61%), mild (n=608; 20%), or moderate to severe (n=588; 19%). Favorable outcome (modified Rankin Scale score, 0–2) was achieved in 838 patients (49%) without WML, 192 patients (34%) with mild WML, and 130 patients (24%) with moderate-to-severe WML. Increasing WML grades were associated with a shift toward poorer functional outcome in a dose-dependent manner (adjusted common odds ratio, 1.34 [95% CI, 1.13–1.60] for mild WML and 1.67 [95% CI, 1.39–2.01] for moderate-to-severe WML; Ptrend, <0.001). Increasing WML grades were associated with futile recanalization (Ptrend, <0.001) and were inversely associated with early neurological recovery (Ptrend, 0.041) but not with the probability of successful reperfusion or symptomatic intracranial hemorrhage. CONCLUSIONS: An increasing burden of WML at baseline is associated with poorer clinical outcomes after endovascular treatment for acute ischemic stroke but not with the probability of successful reperfusion or symptomatic intracranial hemorrhage.
引用
- Uniken Venema SM, Postma AA, van den Wijngaard IR, et al. White Matter Lesions and Outcomes After Endovascular Treatment for Acute Ischemic Stroke: MR CLEAN Registry Results. Stroke. 2021. PMID: 34078103. doi:10.1161/STROKEAHA.120.033334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。